| Preview | Issue Date | Title | Author(s) |
| 2011 | A 13-nation population survey of upper gastrointestinal symptoms: Prevalence of symptoms and socioeconomic factors | Haag, S.; Andrews, J.; Gapasin, J.; Gerken, G.; Keller, A.; Holtmann, G. |
| 2004 | Clinical presentation and personality factors are predictors of the response to treatment in patients with functional dyspepsia - a randomdized, double-blind placebo-controlled crossover study | Holtmann, G.; Kutscher, S.; Haag, S.; Langkafel, M.; Heuft, G.; Neufang-Hueber, J.; Goebell, H.; Senf, W.; Talley, N. |
| 2007 | Disturbed in vitro adrenergic modulation of cytokine production in inflammatory bowel diseases in remission | Lucas, A.; Cobelens, P.; Kavelaars, A.; Heijnen, C.; Holtmann, G.; Haag, S.; Gerken, G.; Langhorst, J.; Dobos, G.; Schedlowski, M.; Elsenbruch, S. |
| 2003 | Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six-week placebo-controlled, double-blind, multicentre trial | Holtmann, G.; Adam, B.; Haag, S.; Collet, W.; Grunewald, E.; Windeck, T. |
| 2004 | G-protein β3 subunit 825CC genotype is associated with unexplained (functional) dyspepsia | Holtmann, G.; Siffert, W.; Haag, S.; Mueller, N.; Langkafel, M.; Senf, W.; Zotz, R.; Talley, N. |
| 2009 | Guideline adherence and patient satisfaction in the treatment of inflammatory bowel disorders - an evaluation study | Pieper, C.; Haag, S.; Gesenhues, S.; Holtmann, G.; Gerken, G.; Jockel, K. |
| 2004 | Heartburn in primary care: problems below the surface | Holtmann, G.; Maldonado-Lopez, E.; Haag, S. |
| 2008 | Impairment of health-related quality of life in functional dyspepsia and chronic liver disease: the influence of depression and anxiety | Haag, S.; Senf, W.; Hauser, W.; Tagay, S.; Grandt, D.; Heuft, G.; Gerken, G.; Talley, N.; Holtmann, G. |
| 2007 | Is there a benefit from intensified medical and psychological interventions in patients with functional dyspepsia not responding to conventional therapy? | Haag, S.; Senf, W.; Tagay, S.; Langkafel, M.; Braun-Lang, U.; Pietsch, A.; Heuft, G.; Talley, N.; Holtmann, G. |
| 2009 | Management of reflux symptoms with over-the-counter proton pump inhibitors: Issues and proposed guidelines | Haag, S.; Andrews, J.; Katelaris, P.; Gapasin, J.; Galmiche, J.; Hunt, R.; Layer, P.; Malfertheiner, P.; Holtmann, G. |
| 2007 | Neuroendocrine and blood pressure responses to rectal distensions in individuals with high and low visceral pain sensitivity | Elsenbruch, S.; Haag, S.; Lucas, A.; Riemenschneider, N.; Pietsch, A.; Gerken, G.; Heijnen, C.; Schedlowski, M.; Holtmann, G. |
| 2010 | Onset of relief of symptoms of gastroesophageal reflux disease: Post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily | Haag, S.; Holtmann, G. |
| 2006 | Public speaking stress-induced neuroendocrine responses and circulating immune cell redistribution in irritable bowel syndrome | Elsenbruch, S.; Lucas, A.; Holtmann, G.; Haag, S.; Gerken, G.; Riemenschneider, N.; Langhorst, J.; Kavelaars, A.; Heijnen, C.; Schedlowski, M. |
| 2009 | Serotoninergic and non-serotoninergic effects of two tricyclic antidepressants on visceral nociception in a rat model | Bechmann, L.; Best, J.; Haag, S.; Leineweber, K.; Gerken, G.; Holtmann, G. |
| 2004 | Symptom patterns in functional dyspepsia and irritable bowel syndrome: relationship to disturbances in gastric emptying and response to a nutrient challenge in consulters and non-consulters | Haag, S.; Talley, N.; Holtmann, G. |
| 2011 | The influence of socioeconomic status on the prevalence of upper gastrointestinal symptoms: a 13-Nation Population Survey | Haag, S.; Andrews, J.M.; Gapasin, J.D.; Keller, A.; Holtmann, G.; Digestive Disease Week (DDW) (7 May 2011 - 10 May 2011 : Chicago, IL) |
